Thymosin Alpha-1 alone for immune suppression without active tissue damage What Each Peptide Actually Does BPC-157 and Thymosin Alpha-1 are often grouped together under the umbrella of "recovery peptides," but their mechanisms are almost entirely separate
L.LiuG.Maple-GrdemJ.CorvolJ
In the wake of the COVID-19 pandemic, a new health concern has emerged: Long COVID
Sermorelin alone patients new to peptide therapy, those focused on sleep and general anti-aging, patients who prefer the simplest daily protocol, and those who value the historically FDA-approved molecule status
In models of brain injury, it helped recovery by reducing oedema, improving the survival of neurons, and reducing inflammation [18,19]
The global peptide therapeutics market reached roughly $48.1 billion in 2025 and search interest in recovery peptides has grown sharply BPC-157 alone draws about 165,000 searches per month